Share This Link

Ceftriaxone: Ceftriaxone is a third-generation cephalosporin used for a wide range of systemic infections, including severe UTIs, pneumonia, and meningitis. It is administered parenterally and distributes widely in body tissues and fluids. It does not act specifically within the urinary tract lumen. Therefore, it is not classified as a urinary antiseptic.

Ciprofloxacin: Ciprofloxacin is a fluoroquinolone antibiotic used for systemic infections, including complicated UTIs and prostatitis. It has broad tissue distribution and acts by inhibiting bacterial DNA gyrase and topoisomerase IV. Although it is used to treat UTIs, it is not a urinary antiseptic because it is not limited to urinary tract action.

Ceftazidime: Ceftazidime is a third-generation cephalosporin with strong activity against gram-negative organisms, including Pseudomonas aeruginosa. It is used for severe systemic infections such as hospital-acquired infections and complicated UTIs. It is administered intravenously and distributes throughout body tissues. It is not classified as a urinary tract antiseptic.

The patient's statement about stopping the drug if diarrhea occurs is a sign of good understanding, particularly regarding the risk of Clostridioides difficile-associated diarrhea (CDAD). Tetracyclines can alter the intestinal flora, leading to the overgrowth of C. difficile. Patients are taught that persistent or severe diarrhea must be reported to the provider, as it may indicate a serious secondary infection requiring clinical evaluation rather than simple management at home.

This statement is accurate and reflects an understanding of the drug's interaction profile. Many antacids contain aluminum, magnesium, or calcium, and certain laxatives may contain magnesium. These substances will chelate with the doxycycline, preventing its absorption in the gut. Consulting a provider before taking these over-the-counter agents is a correct safety precaution to avoid unintended drug-drug interactions that would lower the efficacy of the antibiotic.

This statement correctly reflects the need to avoid calcium-rich substances. Dairy products contain high levels of calcium, which directly binds to the tetracycline molecule to create a non-absorbable chelate complex. Patients must be instructed to separate the administration of the antibiotic from the intake of any dairy products or calcium supplements by at least two to three hours to ensure that the medication is adequately absorbed into the systemic circulation.

Tell the patient to ask for help with ambulation: While dizziness does increase fall risk and safety precautions are important, this action does not address the underlying cause of the symptom. Gentamicin-related dizziness suggests possible vestibular toxicity rather than a simple safety issue alone. The priority is identifying and managing potential drug toxicity.

Tell the patient to report any tinnitus: Tinnitus is indeed an early sign of gentamicin-induced ototoxicity, but in this case the patient is already experiencing neurologic symptoms such as headache and dizziness. This suggests that ototoxicity may already be developing. Waiting for additional symptoms delays necessary intervention. The nurse should act on current findings rather than anticipate future ones.

Request an order for a gentamicin peak level: Monitoring drug levels is important in aminoglycoside therapy to ensure therapeutic dosing. However, in the presence of clinical signs of toxicity, laboratory monitoring alone is insufficient. The priority is to stop further damage by addressing suspected ototoxicity immediately.

Warfarin: Warfarin is an oral anticoagulant used for prevention and treatment of thromboembolic disorders such as DVT, PE, and atrial fibrillation-related stroke prevention. It works by inhibiting vitamin K–dependent clotting factor synthesis. It has no role in reducing uric acid levels or treating inflammatory crystal-induced arthritis. Therefore, it is not used in gout management.

Probenecid: Probenecid is a uricosuric agent that increases renal excretion of uric acid, thereby lowering serum urate levels in chronic gout management. It is used long-term to prevent gout attacks rather than treat acute flares. It is not effective during acute inflammation and may actually worsen symptoms if initiated during a flare. Thus, it is not used as primary therapy for acute gout attacks.

Allopurinol: Allopurinol is a xanthine oxidase inhibitor used for long-term management of gout by decreasing uric acid production. It is typically started after acute inflammation has resolved, as initiating it during an acute flare can worsen symptoms. It is used for chronic prevention rather than immediate treatment.

Sulfasoxazole: Sulfonamides are not first-line therapy for Chlamydia trachomatis and are generally ineffective for intracellular organisms like Chlamydia. Additionally, sulfonamides pose risks in late pregnancy such as kernicterus in the newborn due to bilirubin displacement. They are not recommended for treatment of chlamydial infections.

Erythromycin ethylsuccinate: Erythromycin is a macrolide antibiotic that can be used as an alternative treatment for chlamydia in pregnancy when first-line agents are not suitable. However, it is less effective and associated with more gastrointestinal side effects compared to azithromycin. It may require multiple daily dosing, reducing adherence. While safe, it is not the preferred first-line agent.

Doxycycline: Doxycycline is contraindicated in pregnancy due to risks of permanent tooth discoloration and inhibition of fetal bone growth. It belongs to the tetracycline class, which is avoided in pregnancy and in young children. Although effective against Chlamydia, its safety profile makes it unsuitable for this patient.

Hydrocortisone cream: Hydrocortisone is a topical corticosteroid used to reduce inflammation and pruritus in dermatologic conditions. However, it does not have antifungal activity and can actually worsen fungal infections by suppressing local immune responses. Use of steroids in tinea corporis may mask symptoms and lead to tinea incognito.

Ketoconazole cream: Ketoconazole is a topical azole antifungal effective against dermatophytes and yeast infections. It works by inhibiting ergosterol synthesis, disrupting fungal cell membrane integrity. It is an appropriate treatment option for tinea corporis. However, clotrimazole is more commonly used as first-line topical therapy due to availability and tolerability, making ketoconazole a secondary but still valid option.

Mupirocin ointment: Mupirocin is a topical antibiotic used to treat bacterial skin infections such as impetigo caused by Staphylococcus aureus or Streptococcus pyogenes. It has no antifungal activity and is ineffective against dermatophytes. Since tinea corporis is a fungal infection, mupirocin would not provide therapeutic benefit.

Allowing patients to stop antibiotics when symptoms subside: Stopping antibiotics early leads to incomplete eradication of bacteria, allowing surviving organisms to develop resistance. This practice contributes significantly to antimicrobial resistance and increases the risk of relapse or complications. The CDC strongly discourages discontinuation based on symptom resolution alone.

increased use of antibiotics among parents of young children: Increased antibiotic use without clear indication contributes to resistance development and is not an objective of CDC stewardship programs. Overprescribing in pediatric populations is specifically targeted for reduction, not promotion. Such use increases unnecessary exposure and adverse effects.

Allowing prescribers of develop their own prescribing guidelines: While clinical judgment is important, CDC initiatives emphasize standardized, evidence-based prescribing guidelines to reduce variability and inappropriate use. Allowing unrestricted individual guideline creation could increase inconsistency and misuse. Stewardship programs aim for adherence to established protocols, not independent guideline development.

I need to use sunscreen when taking this drug: Sulfonamides can cause significant photosensitivity reactions due to increased sensitivity of the skin to ultraviolet radiation. Patients are at risk for exaggerated sunburn, erythema, and skin rashes even with limited sun exposure. Preventive measures such as sunscreen use, protective clothing, and avoiding peak sunlight hours are recommended.

I need to drink extra fluids while taking this medication: Increased fluid intake is essential during sulfonamide therapy to reduce the risk of crystalluria and kidney stone formation. Adequate hydration promotes urinary dilution and prevents drug crystal precipitation in the renal tubules. This reduces the likelihood of renal irritation or obstruction.

I should call my provider if I develop a rash while taking this drug: Rash during sulfonamide therapy may indicate a hypersensitivity reaction ranging from mild dermatitis to severe reactions such as Stevens-Johnson syndrome. Early reporting allows for prompt evaluation and discontinuation of the drug if necessary. Timely intervention can prevent progression to life-threatening complications.